ArticleFrontiers in pharmacology2022

Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model.

Karolina Seborova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.